Nanoparticle-in-Hydrogel Delivery System for the Sequential Release of Two Drugs
Background/Objectives: Glioblastoma is the most common and lethal primary brain tumor. Patients often suffer from tumor- and treatment induced vasogenic edema, with devastating neurological consequences. Intracranial edema is effectively treated with dexamethasone. However, systemic dexamethasone re...
Saved in:
| Main Authors: | Demian van Straten, Jaime Fernández Bimbo, Wim E. Hennink, Tina Vermonden, Raymond M. Schiffelers |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/1/127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Injectable sustainable andrographolide-releasing hydrogel for long-lasting alleviation of osteoarthritis and regulation of chondrocyte autophagy via PRKCA/EGFR
by: Yang Chen, et al.
Published: (2025-04-01) -
Gellan Gum-Based In Situ Hydrogels for Nasal Delivery of Polymeric Micelles Loaded with Risperidone
by: Bence Sipos, et al.
Published: (2025-05-01) -
Nanostructured Strategies for Melanoma Treatment—Part II: Targeted Topical Delivery of Curcumin via Poloxamer-Based Thermosensitive Hydrogels
by: Valentina Paganini, et al.
Published: (2025-02-01) -
Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery
by: Thi-Thao-Linh Nguyen, et al.
Published: (2025-04-01) -
The recent research progress in the application of the nanozyme-hydrogel composite system for drug delivery
by: Haichang Li, et al.
Published: (2024-12-01)